Fresenius Medical Care AG & Co KGaA
XETRA:FME
Relative Value
The Relative Value of one FME stock under the Base Case scenario is 95.92 EUR. Compared to the current market price of 39.18 EUR, Fresenius Medical Care AG & Co KGaA is Undervalued by 59%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
FME Competitors Multiples
Fresenius Medical Care AG & Co KGaA Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.5B EUR | 0.6 | 23.1 | 6.9 | 16.3 | |
US |
C
|
Cigna Group
XMUN:CGN
|
94.9B EUR | 0.5 | 19.8 | 10.2 | 13.6 | |
US |
Cigna Corp
NYSE:CI
|
99.9B USD | 0.5 | 19.3 | 10 | 13.3 | ||
US |
CVS Health Corp
NYSE:CVS
|
70B USD | 0.2 | 9.6 | 8.7 | 8.7 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 1.4 | 39.2 | 11.9 | 18 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.7B EUR | 0.7 | -26.5 | 10.1 | 22.6 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.2B USD | 1.6 | 18.1 | 10.8 | 14.6 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.9B EUR | 0.6 | 23.9 | 7 | 16.6 | ||
US |
DaVita Inc
NYSE:DVA
|
11.9B USD | 1 | 17.3 | 8.4 | 12.4 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 | ||
US |
Chemed Corp
NYSE:CHE
|
8.5B USD | 3.7 | 30 | 18.8 | 21.9 |